BioPharma Credit PLC Dividend Declaration (5959J)
28 April 2022 - 2:15AM
UK Regulatory
TIDMBPCR
RNS Number : 5959J
BioPharma Credit PLC
27 April 2022
BIOPHARMA CREDIT PLC
("BIOPHARMA CREDIT" OR THE "COMPANY")
DIVIDEND DECLARATION
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences
debt investor, is pleased to declare an interim dividend in respect
of the financial period ending 31 March 2022 of $0.0175 per
ordinary share, payable on 31 May 2022 to ordinary shareholders on
the register as at 6 May 2022. The Company has chosen to designate
the entire amount of this interim dividend as an interest
distribution. Shareholders in receipt of such a dividend will be
treated for UK tax purposes as though they have received a payment
of interest. This will result in a reduction in the corporation tax
payable by the Company.
The Company is currently paying and continues to target a 7 cent
annual dividend per ordinary share.
The default payment for dividends is in US dollars. However,
shareholders can elect to have dividends paid in sterling (GBP) and
the option to elect a sterling dividend payment for this dividend
will be available to shareholders until 6 May 2022 (the "Election
Date").
Further details together with a copy of the Dividend Currency
Election Form, which should be sent to Link Group, 10th Floor,
Central Square, 29 Wellington Street, Leeds LS1 4DL when completed,
will be available on the Group's website shortly at
www.bpcruk.com/investor-materials . CREST shareholders must elect
via CREST. Further details together with a copy of the Dividend
Currency Election Form, which should be sent to Link Group, 10th
Floor, Central Square, 29 Wellington Street, Leeds LS1 4DL when
completed, will be available on the Group's website shortly at
www.bpcruk.com/investor-materials . CREST shareholders must elect
via CREST.
LEI: 213800AV55PYXAS7SY24
-Ends-
Link Company Matters Limited
Company Secretary
27 April 2022
Enquiries:
Buchanan
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
+44 (0)20 7466 5000
Biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DIVIRMFTMTBTBTT
(END) Dow Jones Newswires
April 27, 2022 12:15 ET (16:15 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2024 to May 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024